For full functionality, it is necessary to enable JavaScript. Here are instructions how to enable JavaScript in your web browser.

Welcome to Medical News Today

Healthline Media, Inc. would like to process and share personal data (e.g., mobile ad id) and data about your use of our site (e.g., content interests) with our third party partners (see a current list) using cookies and similar automatic collection tools in order to a) personalize content and/or offers on our site or other sites, b) communicate with you upon request, and/or c) for additional reasons upon notice and, when applicable, with your consent.

Healthline Media, Inc. is based in and operates this site from the United States. Any data you provide will be primarily stored and processed in the United States, pursuant to the laws of the United States, which may provide lesser privacy protections than European Economic Area countries.

By clicking “accept” below, you acknowledge and grant your consent for these activities unless and until you withdraw your consent using our rights request form. Learn more in our Privacy Policy.

Suit Against Medtronic Is Dismissed

Published Friday 13 March 2009 Published Fri 13 Mar 2009

Adapted Media Release

Medtronic, Inc. (NYSE:MDT) today announced that a securities class action lawsuit against the company was dismissed by U.S. District Judge Richard Kyle of Minnesota.

The complaint, which was filed initially by Stanley Kurzweil on behalf of all shareholders and amended on April 18, 2008 after consolidation with other similar shareholder suits, involved the company's October 2007 withdrawal of its Sprint Fidelis defibrillator leads.

In a 42-page ruling, Kyle analyzed each of the allegations against Medtronic and concluded that, even assuming the allegations were true, they could not support a claim for securities fraud under the laws governing shareholder class actions. Kyle also ruled that the plaintiffs may not amend their complaint.

About Medtronic

Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

Medtronic

Related coverage

Blocking fatty acids slows prostate cancer progression New research in mice finds that fatty acids fuel prostate tumor growth and that blocking the uptake of fatty acids slows cancer progression. Read now

How sleep can boost your body's immune response New research pinpoints the mechanism through which sleep helps boost the activity of immune cells, thereby enhancing the body's immune response. Read now

Can these new compounds treat memory loss in depression? Researchers have developed novel compounds that may be able to reverse memory loss that relates to depression and other mental health conditions. Read now

New tool predicts kidney stone recurrence Despite the prevalence of kidney stones, it is still difficult to predict who will experience recurrence. A new tool promises to make prediction easier. Read now

Breast cancer: Cut down on alcohol to lower risk The results of a new study show that Australian women remain unaware of the fact that alcohol consumption really does increase breast cancer risk. Read now

email email

Litigation / Medical Malpractice

Medical Devices / Diagnostics

APA
Medtronic, . (2009, March 13). "Suit Against Medtronic Is Dismissed." Medical News Today. Retrieved from
https://www.medicalnewstoday.com/releases/142211.php.

Please note: If no author information is provided, the source is cited instead.